• Orum Therapeutics will hold an extraordinary shareholder meeting on Oct. 23, 2026 in Daejeon, South Korea.
• Shareholders will vote on appointing Geoffrey Harris Meyerson as a non-executive director.
• Vote scheduled on appointing Peter Unnam Park as an independent director.
• Resolutions include granting stock options, ratifying previously granted stock options, and amending the articles of incorporation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orum Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000653), on October 08, 2026, and is solely responsible for the information contained therein.